PRGO

#2045
Perrigo Company plc Ordinary Shares
10.7 0 USD
+9574.50%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
10.60
10.72
Intervallo Annuale
0.11
22.01
Variazione giornaliera
+9574.50%
Variazione Mensile
-9.86%
Variazione di 6 mesi
-22.41%
Variazione Annuale
-50.28%
Chiusura Precedente
0.1 1
Open
10.6 3
Minimo
10.6 0
High
10.7 2
Volume
145
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche Dividendi
Trimestrale Annuale
  • Market Capitalization 1.48 B
  • Employee 8 100
  • Founded N/A
  • CEO Murray S. Kessler
  • Website www.perrigo.com
  • Headquarter Ireland
  • FIGI N/A
  • Industry Case Farmaceutiche - Specialistico e Generico
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.74
Rapporto prezzo/fatturato
0.32
Dividendi per azione
0.29
Rendimento da dividendi %
20.88

Perrigo Company plc Ordinary Shares

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park. Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value.

Notizie